Cholinergic blockade reveals a role for human hippocampal theta in memory encoding but not retrieval
Cholinergic dysfunction is a hallmark of Alzheimer’s disease and other memory disorders. Yet, the neurophysiological mechanisms linking cholinergic signaling to memory remain poorly understood. In this study, we administered scopolamine, a muscarinic cholinergic antagonist, to neurosurgical patients with intracranial electrodes as they performed an associative recognition memory task. When…
In a study examining the impact of cholinergic dysfunction on memory encoding and retrieval, researchers administered scopolamine, a muscarinic cholinergic antagonist, to neurosurgical patients equipped with intracranial electrodes. The patients performed an associative recognition memory task.
Scopolamine administered during encoding disrupted hippocampal slow theta oscillations (2–4 Hz). This disruption selectively impaired recollection-based memory. However, when scopolamine was present only during retrieval, there were disruptions to slow theta oscillations without any impairment in memory performance.
These disruptions included dose-dependent reductions in theta power, theta phase reset, and encoding-retrieval pattern reinstatement. By these findings, the researchers challenge the traditional belief that theta oscillations are necessary for memory retrieval. Instead, they propose that theta oscillations universally reflect an encoding-related neural state.
These findings call for revisions to current models of acetylcholine's role in memory. They also suggest potential future therapies targeting rhythmic biomarkers of memory dysfunction.
Rewritten by urgent.news; may contain errors — check the original.
Source: elifesciences.org